Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays

Arthritis Research and Therapy

Volumn 8, Issue 4, 2006, Pages

  Vander Cruyssen, Bert ^a   Cantaert, Tineke ^a   Nogueira, Leonor ^b   Clavel, Cyril ^b   De Rycke, Leen ^a   Dendoven, Amélie ^a   Sebag, Mireille ^b   Deforce, Dieter ^c   Vincent, Christian ^b   Elewaut, Dirk ^a   Serre, Guy ^b   De Keyser, Filip ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b CNRS   (France)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CITRULLINE; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE; FIBRINOGEN; ISOPROTEIN; RHEUMATOID FACTOR;

ADOLESCENT; ADULT; AGED; ARTHRITIS, RHEUMATOID; BLOOD; CHILD; COHORT ANALYSIS; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION STUDY; FEMALE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; RHEUMATIC DISEASES; STANDARDS; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; ARTHRITIS, RHEUMATOID; CHILD; CITRULLINE; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOGEN; HUMANS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; PROTEIN ISOFORMS; RHEUMATIC DISEASES; RHEUMATOID FACTOR;

EID: 70350554075     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2011     Document Type: Article

References (29)

1. Grigor C, Capell H, Stirling A, McMahon AD, Lock P, Vallance R, Kincaid W, Porter D: Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): A single-blind randomised controlled trial. Lancet 2004, 364:263-269.
2. van Boekel MA, Vossenaar ER, van den Hoogen FH, van Venrooij WJ: Autoantibody systems in rheumatoid arthritis: Specificity, sensitivity and diagnostic value. Arthritis Res 2002, 4:87-93.
3. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
4. Girbal-Neuhauser E, Durieux JJ, Arnaud M, Dalbon P, Sebbag M, Vincent C, Simon M, Senshu T, Masson-Bessiere C, Jolivet-Reynaud C, et al.: The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol 1999, 162:585-594.
5. Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ: Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritisspecific autoantibodies J Clin Invest 1998, 101:273-281.
6. Young BJ, Mallya RK, Leslie RD, Clark CJ, Hamblin TJ: Anti-keratin antibodies in rheumatoid arthritis. Br Med J 1979, 2 97-99.
7. Nienhuis RL, Mandema E: A new serum factor in patients with rheumatoid arthritis: The antiperinuclear factor. Ann Rheum Dis 1964, 23:302-305.
8. Sebbag M, Simon M, Vincent C, Masson-Bessiere C, Girbal E, Durieux JJ, Serre G: The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. J Clin Invest 1995, 95:2672-2679.
9. Nogueira L, Sebbag M, Vincent C, Arnaud M, Fournie B, Cantagrel A, Jolivet M, Serre G: Performance of two ELISAs for antifilaggrin autoantibodies, using either affinity purified or deiminated recombinant human filaggrin, in the diagnosis of rheumatoid arthritis. Ann Rheum Dis 2001, 60:882-887.
10. Vincent C, Nogueira L, Sebbag M, Chapuy-Regaud S, Arnaud M, Letourneur O, Rolland D, Fournie B, Cantagrel A, Jolivet M, et al.: Detection of antibodies to deiminated recombinant rat filaggrin by enzyme-linked immunosorbent assay: A highly effective test for the diagnosis of rheumatoid arthritis. Arthritis Rheum 2002, 46 2051-2058.
11. Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, van Venrooij WJ: The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000, 43:155-163.
12. Bizzaro N, Mazzanti G, Tonutti E, Villalta D, Tozzoli R: Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis Clin Chem 2001, 47:1089-1093.
13. Union A, Meheus L, Humbel RL, Conrad K, Steiner G, Moereels H, Pottel H, Serre G, De Keyser F: Identification of citrullinated rheumatoid arthritis-specific epitopes in natural filaggrin relevant for antifilaggrin autoantibody detection by line immunoassay. Arthritis Rheum 2002, 46:1185-1195.
14. De Rycke L, Peene I, Hoffman IE, Kruithof E, Union A, Meheus L, Lebeer K, Wyns B, Vincent C, Mielants H, et al.: Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: Diagnostic value, associations with radiological progression rate, and extra-articular manifestations. Ann Rheum Dis 2004, 63 1587-1593.
15. Dubucquoi S, Solau-Gervais E, Lefranc D, Marguerie L, Sibilia J, Goetz J, Dutoit V, Fauchais AL, Hachulla E, Flipo, et al.: Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases. Ann Rheum Dis 2004, 63 415-419.
16. Pinheiro GC, Scheinberg MA, Aparecida da Silva M, Maciel S: Anti-cyclic citrullinated peptide antibodies in advanced rheumatoid arthritis. Ann Intern Med 2003, 139:234-235.
17. Masson-Bessiere C, Sebbag M, Girbal-Neuhauser E, Nogueira L, Vincent C, Senshu T, Serre G: The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J Immunol 2001, 166 4177-4184.
18. Nogueira, Chapuy-Regaud S, Constantin A, Clavel C, Sebbag M, Cantagrel A, Vincent C, Serre G: Autoantibodies to deiminated fibrinogen are the most efficient serological criterion for the diagnosis of rheumatoid arthritis. Arthritis Res 2002, 4 (Suppl 1):90.
19. Nielen MM, van der Horst AR, van Schaardenburg D, van der Horst-Bruinsma IE, van de Stadt RJ, Aarden L, Dijkmans BA, Hamann D: Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis. Ann Rheum Dis 2005, 64 1199-1204.
20. Chapuy-Regaud S, Nogueira L, Clavel C, Sebbag M, Vincent C, Serre G: IgG subclass distribution of the rheumatoid arthritisspecific autoantibodies to citrullinated fibrin. Clin Exp Immunol 2005, 139:542-550.
21. Hanley JA, McNeil BJ: A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983, 148:839-843.
22. Visser H, le Cessie S, Vos K, Breedveld FC, Hazes JM: How to diagnose rheumatoid arthritis early: A prediction model for persistent (erosive) arthritis. Arthritis Rheum 2002, 46:357-365.
23. Nell VP, Machold KP, Stamm TA, Eberl G, Heinzl H, Uffmann M, Smolen JS, Steiner G: Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann Rheum Dis 2005, 64 1731-1736.
24. Vander Cruyssen B, Peene I, Cantaert T, Hoffman IE, De Rycke L, Veys EM, De Keyser F: Anti-citrullinated protein/peptide antibodies (ACPA) in rheumatoid arthritis: Specificity and relation with rheumatoid factor Autoimmun Rev 2005, 4:468-474.
25. Vossenaar ER, Van Venrooij WJ: Anti-CCP antibody, a highly specific marker for (early) rheumatoid arthritis. Clin Appl Immunol Rev 2004, 4:239-262.
26. Chapuy-Regaud S, Sebbag M, Baeten D, Clavel C, Foulquier C, De Keyser F, Serre G: Fibrin deimination in synovial tissue is not specific for rheumatoid arthritis but commonly occurs during synovitides. J Immunol 2005, 174:5057-5064.
27. Hueber W, Kidd BA, Tomooka BH, Lee BJ, Bruce B, Fries JF, Sonderstrup G, Monach P, Drijfhout JW, van Venrooij WJ, et al.: Antigen microarray profiling of autoantibodies in rheumatoid arthritis. Arthritis Rheum 2005, 52:2645-2655.
28. Huizinga TW, Amos CI, van der Helm-van Mil AH, Chen W, van Gaalen FA, Jawaheer D, Schreuder GM, Wener M, Breedveld FC, Ahmad N, et al.: Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Arthritis Rheum 2005, 52 3433-3458.
29. van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Huizinga TW, Toes RE, de Vries RR: The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis. Arthritis Rheum 2006, 54:1117-1121.